Panel Discusses Financing of Transformative Therapies

June 10, 2020

A panel discussion offers multiple perspectives into the requirements and challenges involved with value-based contracting models for transformative therapies.

The on-demand discussion, moderated by Aetion’s Maya Tsukernik, is part of BIO Digital 2020.

Featured speakers include:

  • Doug Danison, bluebird bio;
  • Neal Masia, Health Capital Group;
  • Cristina Masseria, Pfizer; and
  • Steve Miller, Cigna Corporation.

To learn more about this discussion, click here.

Share This Story!